Optibrium appoints James Halle as Chief Commercial Officer

FHS
July 16, 2024
9:53 am

Key appointment brings extensive software commercial experience to drive global growth.

Amy Abernethy, former No. 2 at FDA, outlines new company’s plans to streamline clinical research

Former Verily executive Amy Abernethy outlined her plan to streamline clinical research on Thursday, revealing the first projects that her company, Highlander Health, will fund.

October 17, 2024

The 9th Joint ECTRIMS-ACTRIMS Meeting – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Study results/Conference 11.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents

October 12, 2023

Seasonal training shifts don’t shake rugby players’ heart health, finds study

In a comprehensive study examining cardiac function in male Rugby Football League (RFL) players, researchers found that cardiovascular health remains stable across different phases of

October 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.